mProX™ Human ILDR2 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Immune Checkpoint Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
There are currently no Customer reviews or questions for mProX™ Human ILDR2 Stable Cell Line (S01YF-1023-PY198). Click the button above to contact us or submit your feedback about this product.
Peyton Williams (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Cameron Jones (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Published Data
Fig.1 The inhibition of ILDR2 expression through the use of inhibitors for GRP78 and PDIA1 was investigated, with a focus on passive voice construction.
FLAG-tagged ILDR2 adenovirus was used to infect MIN6 cells, which were then subjected to incubation with specific drugs at different time points after 48 hours of infection. Subsequently, whole cell lysates were prepared and subjected to western blotting, employing anti-FLAG, anti-GRP78, anti-PDIA1, and anti-β-actin antibodies. The quantification of relative protein levels for ILDR2, GRP78, and PDIA1 by western blot was conducted, with normalization based on β-actin levels. Each group consisted of three replicates.
Ref: Watanabe, Kazuhisa, et al. "ILDR2 stabilization is regulated by its interaction with GRP78." Scientific reports 11.1 (2021): 8414.
Pubmed: 33863978
DOI: 10.1038/s41598-021-87884-7
Research Highlights
Sabaie, Hani. et al. "Expression analysis of inhibitory B7 family members in Alzheimer's disease." Metabolic brain disease, 2023.
The global health issue of Alzheimer's disease (AD) is challenging due to its complex nature, making the development of effective treatments difficult. Therefore, there is a need for new methodologies to further understand the pathology of AD and develop treatments. The use of immune modulation in promoting neurodegeneration has expanded the understanding of AD and presents a promising opportunity for identifying new biomarkers and therapies. The expression levels of immune regulator genes from the B7 family were compared between late-onset AD (LOAD) patients (n = 50) and healthy individuals (n = 50) through quantitative polymerase chain reaction. The results showed significantly higher levels of B7-2, B7-H4, ILDR2, and B7-DC in LOAD patient blood samples compared to control samples. A positive correlation was also found in the expression levels of all genes. Moreover, ILDR2, B7-H4, B7-2, and B7-DC were identified as potential diagnostic biomarkers for distinguishing between LOAD patients and healthy individuals. These findings further support the role of inhibitory B7 family members in the development of LOAD.
Sabaie, Hani. et al. "Expression analysis of inhibitory B7 family members in Alzheimer's disease." Metabolic brain disease, 2023.
Pubmed:
37665469
DOI:
10.1007/s11011-023-01274-8
F Gerlach, Gary. et al. "Mapping of the podocin proximity-dependent proteome reveals novel components of the kidney podocyte foot process." Frontiers in cell and developmental biology, 2023.
This article explores the concept of identity and how it is socially constructed through relationships and interactions. It examines the impact of societal norms and expectations on individual self-perception and the role of communication in shaping identity. Through a review of existing literature and personal anecdotes, the author presents a nuanced understanding of identity formation and the complex interplay between self and society. By acknowledging the fluid nature of identity, this abstract challenges the notion of a fixed self and invites a deeper exploration of individual and collective identities.
F Gerlach, Gary. et al. "Mapping of the podocin proximity-dependent proteome reveals novel components of the kidney podocyte foot process." Frontiers in cell and developmental biology, 2023.
Pubmed:
37325559
DOI:
10.3389/fcell.2023.1195037